Cite
APA Citation
Robinson, P. C., Richards, D., Tanner, H. L., & Feldmann, M. (2020). accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. Lancet, 2, e653–e655. http://access.bl.uk/ark:/81055/vdc_100113686552.0x000001